Gangli An

A novel CD7 chimeric antigen receptor-modified NK-92MI cell line targeting T-cell acute lymphoblastic leukemia.

Fengtao You, Yinyan Wang, Licui Jiang et al. · PubMed · 2019 · 130 citations · Full text

Life Sciences, Immunology, Oncology +12

Novel CD7-specific nanobody-based immunotoxins potently enhanced apoptosis of CD7-positive malignant cells

Jinle Tang, Jialu Li, Xuejun Zhu et al. · Oncotarget · 2016 · 53 citations · Full text

Medicine, Hematology, Oncology +11

Gene-modified NK-92MI cells expressing a chimeric CD16-BB-ζ or CD64-BB-ζ receptor exhibit enhanced cancer-killing ability in combination with therapeutic antibody

Ying Chen, Fengtao You, Licui Jiang et al. · Oncotarget · 2017 · 53 citations · Full text

Life Sciences, Immunology, Oncology +17

Immunotherapy based on bispecific T‐cell engager with <scp>hIgG</scp>1 Fc sequence as a new therapeutic strategy in multiple myeloma

Jianxuan Zou, Dan Chen, Yunhui Zong et al. · Cancer Science · 2015 · 48 citations · Full text

Medicine, Immunology, Oncology +17

The zinc finger transcription factor ZKSCAN3 promotes prostate cancer cell migration

Jing Yu, Yang Qin, Sally A. Hunsucker et al. · The International Journal of Biochemistry & Cell Biology · 2012 · 46 citations · Full text

Medicine, Molecular Biology, Oncology +13